Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(67%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

33%

Ph phase_1

33%

Ph phase_2

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Detailed Status

Recruiting2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

N/A1 (33.3%)

Trials by Status

completed133%

recruiting267%

Recent Activity

2 active trials

Showing 3 of 3

recruitingphase_2

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

NCT07517445

recruitingphase_1

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors

NCT06882096

completednot_applicable

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

NCT05517122

Clinical Trials (3)

Showing 3 of 3 trials

NCT07517445Phase 2

Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis

Recruiting

NCT06882096Phase 1

Tracing the Metabolic Flux of Orally Administered NAD+ Precursors

Recruiting

NCT05517122Not Applicable

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

Completed

All 3 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 3